Надана інформація про лікарські засоби призначена виключно для ознайомлення і не є офертою, рекламою чи інструкцією щодо застосування. Продаж, доставка та призначення препаратів через сайт не здійснюються. З питань застосування препарату ви можете записатися на очний прийом або онлайн-консультацію до профільного спеціаліста нашої клініки.
HYADROL (ITALY)
Composition
• Water for injection solutions
• Adelmidrol
• Sodium hyaluronate
• Sodium chloride
• Monohydrate potassium dihydrogen phosphate
• Disodium EDTA
• Sodium hydrate
• Water for injection solutions
• Adelmidrol
• Sodium hyaluronate
• Sodium chloride
• Monohydrate potassium dihydrogen phosphate
• Disodium EDTA
• Sodium hydrate
130у.е.
HYADROL® 2 ml in a pre-filled syringe
Sterile single-use medical device for intra-articular injections. The use of HYADROL® is permitted only by qualified medical personnel under appropriate conditions and in compliance with the technical standards required for intra-articular administration. Medical device Hyadrol Project Bones and joints are characterized by a complex network of immune cells and sensory nerve fibers that play a key role in protection and pain perception. Pain often serves as a warning signal of joint diseases such as osteoarthritis. Modern scientific research has revealed that low-grade chronic neuroinflammation is the main mechanism underlying joint dysmetabolic disorders and their associated symptoms, including pain, swelling, and joint stiffness. With the Hyadrol project, the Epitech group aims to offer new therapeutic strategies to control the process of neuroinflammation associated with degenerative joint diseases.
HYADROL Description HYADROL is a Class III medical device, sterile and single-use, intended for intra-articular administration. It is a colorless, viscous, and transparent liquid with a neutral pH level (6.5/7.5). It consists of hyaluronic acid (1%) and adelmidrol (2%). The device does not contain derivatives of human blood, tissues, or substances of animal origin. It also does not include medicinal substances as an integral part. The device is intended to optimize the natural process of viscoelastic lubrication of the joint capsule, supported by hyaluronic acid, in the treatment of dysmetabolic disorders associated with degenerative arthropathy. Method of application One intra-articular injection every 7 days for 5 weeks, unless otherwise medically advised. Use a sterile needle of appropriate size (from 18 G to 27 G). The administration of HYADROL should be performed exclusively by qualified medical personnel.
Sterile single-use medical device for intra-articular injections. The use of HYADROL® is permitted only by qualified medical personnel under appropriate conditions and in compliance with the technical standards required for intra-articular administration. Medical device Hyadrol Project Bones and joints are characterized by a complex network of immune cells and sensory nerve fibers that play a key role in protection and pain perception. Pain often serves as a warning signal of joint diseases such as osteoarthritis. Modern scientific research has revealed that low-grade chronic neuroinflammation is the main mechanism underlying joint dysmetabolic disorders and their associated symptoms, including pain, swelling, and joint stiffness. With the Hyadrol project, the Epitech group aims to offer new therapeutic strategies to control the process of neuroinflammation associated with degenerative joint diseases.
HYADROL Description HYADROL is a Class III medical device, sterile and single-use, intended for intra-articular administration. It is a colorless, viscous, and transparent liquid with a neutral pH level (6.5/7.5). It consists of hyaluronic acid (1%) and adelmidrol (2%). The device does not contain derivatives of human blood, tissues, or substances of animal origin. It also does not include medicinal substances as an integral part. The device is intended to optimize the natural process of viscoelastic lubrication of the joint capsule, supported by hyaluronic acid, in the treatment of dysmetabolic disorders associated with degenerative arthropathy. Method of application One intra-articular injection every 7 days for 5 weeks, unless otherwise medically advised. Use a sterile needle of appropriate size (from 18 G to 27 G). The administration of HYADROL should be performed exclusively by qualified medical personnel.
